YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558)

HKG:1558 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,492	8,412	8,351	5,720	5,368	7,770
Market Cap Growth	0.74%	0.74%	46.00%	6.56%	-30.92%	-60.53%
Enterprise Value	12,373	9,289	9,299	9,130	7,738	7,962
Last Close Price	13.06	9.56	9.49	6.50	6.10	8.83
PE Ratio	22.37	16.38	3.80	66.05	-	7.79
Forward PE	7.25	5.08	4.49	7.63	10.57	4.66
PS Ratio	2.90	2.12	1.20	1.35	4.79	2.79
PB Ratio	1.27	0.93	0.96	0.83	0.73	1.28
P/TBV Ratio	1.48	1.08	1.17	1.23	1.19	2.00
P/FCF Ratio	-	-	5.70	4.48	-	21.43
P/OCF Ratio	120.77	88.41	4.53	2.98	-	5.04
EV/Sales Ratio	3.12	2.34	1.34	2.16	6.90	2.86
EV/EBITDA Ratio	10.92	8.29	2.66	11.68	-	7.06
EV/EBIT Ratio	17.37	13.05	3.03	25.02	-	8.04
EV/FCF Ratio	-13.23	-	6.35	7.15	-	21.96
Debt / Equity Ratio	0.26	0.26	0.33	0.63	0.53	0.59
Debt / EBITDA Ratio	2.10	2.10	0.82	5.46	-	3.15
Debt / FCF Ratio	-	-	1.96	3.38	-	9.86
Asset Turnover	0.30	0.30	0.51	0.33	0.09	0.24
Inventory Turnover	1.76	1.76	3.62	3.02	1.31	1.20
Quick Ratio	1.29	1.29	0.87	0.46	1.36	0.64
Current Ratio	1.77	1.77	1.40	1.01	1.66	0.78
Return on Equity (ROE)	5.87%	5.87%	26.50%	0.81%	-10.57%	17.22%
Return on Assets (ROA)	3.32%	3.32%	14.16%	1.80%	-2.85%	5.35%
Return on Capital (ROIC)	3.93%	3.93%	17.07%	2.11%	-3.30%	6.61%
Return on Capital Employed (ROCE)	7.00%	7.00%	33.20%	4.60%	-	15.40%
Earnings Yield	4.47%	6.11%	26.29%	1.51%	-13.44%	12.83%
FCF Yield	-8.14%	-11.12%	17.54%	22.33%	-23.30%	4.67%
Dividend Yield	-	-	-	-	-	1.34%
Payout Ratio	-	-	-	-	-	26.21%
Buyback Yield / Dilution	-	-	-	-	20.42%	-9.51%
Total Shareholder Return	-	-	-	-	20.42%	-8.17%

Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.